| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $4.3B | $3.7B | $3.7B | $3.1B | $1.2B | $1.2B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | $2.7B | $2.1B | $2.3B | $1.9B | $0.7B | $0.7B | $0.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.5B | $0.1B | $0.3B | $-0.0B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.6B | $0.3B | $0.0B | $-0.1B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $11.14 | $6.53 | $0.06 | $4.41 | $-1.82 | $1.32 | $1.47 | $1.08 |
| EPS (Diluted) | $10.69 | $6.22 | $0.05 | $4.20 | $-1.82 | $1.29 | $1.42 | $1.05 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.3B | $3.0B | $2.7B | $2.9B | $3.3B | $3.5B | $2.4B | $2.3B |
| Current Assets | $1.7B | $1.5B | $1.2B | $1.5B | $1.7B | $1.3B | $1.3B | $1.3B |
| Cash & Equivalents | $0.8B | $0.9B | $0.5B | $0.8B | $1.1B | $0.7B | $0.7B | $0.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.1B | $1.0B | $0.9B | $1.0B | $1.0B | $0.8B | $0.6B | $0.5B |
| Stockholders' Equity | $1.3B | $1.0B | $0.7B | $0.8B | $0.9B | $1.1B | $1.2B | $1.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.7B | $-0.0B | $0.3B | $0.4B | $0.3B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.3B | $-0.2B | $-0.1B | $-0.1B | $-0.1B | $-0.2B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.5B | $-0.1B | $-0.2B | $-0.4B | $0.1B | $-0.1B | $-0.1B | $-0.1B |